Novartis Ag (NVS) Non Operating Income (2009 - 2024)
Novartis Ag recorded quarterly Non Operating Income of $215.0 million in Q1 2024, up 123.96% quarter-over-quarter from $96.0 million in Q1 2023, and up 123.96% year-over-year from $96.0 million in Q2 2023.
Novartis Ag's Non Operating Income history runs 11 years deep, the most recent figure standing at $215.0 million for Q1 2024.
- In Q1 2024, Non Operating Income rose 123.96% year-over-year to $215.0 million; the TTM figure through Mar 2024 stood at $215.0 million (up 123.96% YoY), while the FY2017 annual figure was $738.0 million, up 38.46% from the prior year.
- Non Operating Income came in at $215.0 million for Q1 2024 at Novartis Ag, up from $96.0 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $215.0 million in Q1 2024 to a low of $96.0 million in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -65.00 Mn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -294.00 Mn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -2.31 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -138.00 Mn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 75.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 235.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -861.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -32.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 215.00 Mn |
| Mar 31, 2023 | 96.00 Mn |
| Dec 31, 2017 | 185.00 Mn |
| Sep 30, 2017 | 183.00 Mn |
| Jun 30, 2017 | 180.00 Mn |
| Mar 31, 2017 | 190.00 Mn |
| Dec 31, 2016 | 533.00 Mn |
| Sep 30, 2016 | 212.00 Mn |
| Jun 30, 2016 | 183.00 Mn |
| Mar 31, 2016 | 226.00 Mn |
| Dec 31, 2015 | 556.00 Mn |
| Sep 30, 2015 | 185.00 Mn |
| Jun 30, 2015 | 246.00 |
| Mar 31, 2015 | 122.00 |
| Dec 31, 2014 | 175.00 |
| Sep 30, 2014 | 145.00 |
| Jun 30, 2014 | 222.00 |
| Mar 31, 2014 | 193.00 |
| Dec 31, 2013 | 205.00 |
| Sep 30, 2013 | 232.00 |
| Jun 30, 2013 | 170.00 |
| Mar 31, 2013 | 168.00 |
| Sep 30, 2012 | 248.00 |
| Jun 30, 2012 | 149.00 |
| Mar 31, 2012 | 205.00 |
| Dec 31, 2011 | 186.00 |
| Sep 30, 2011 | 194.00 |
| Jun 30, 2011 | 207.00 |
| Mar 31, 2011 | 167.00 |
| Dec 31, 2010 | 222.00 |
| Sep 30, 2010 | 161.00 |
| Jun 30, 2010 | 161.00 |
| Mar 31, 2010 | 84.00 |
| Dec 31, 2009 | 52.00 |
| Sep 30, 2009 | 122.00 |
| Mar 31, 2009 | 134.00 |